Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Pembrolizumab for Thyroid Cancer
Recruiting1 awardPhase 2
Palo Alto, California
This trial is testing a new immunotherapy drug to see if it can extend the lives of patients with an aggressive form of thyroid cancer who have no other treatment options.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.